RAMPs as drug targets

Patrick M Sexton, David R Poyner, John Simms, Arthur Christopoulos, Debbie L Hay

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.
Original languageEnglish
Title of host publicationRAMPs
EditorsW S Spielman, N Parameswaran
Place of PublicationUSA
PublisherSpringer
Pages61 - 74
Number of pages14
Edition1st
ISBN (Print)9781461423638
DOIs
Publication statusPublished - 2012

Cite this

Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2012). RAMPs as drug targets. In W. S. Spielman, & N. Parameswaran (Eds.), RAMPs (1st ed., pp. 61 - 74). USA: Springer. https://doi.org/10.1007/978-1-4614-2364-5_6
Sexton, Patrick M ; Poyner, David R ; Simms, John ; Christopoulos, Arthur ; Hay, Debbie L. / RAMPs as drug targets. RAMPs. editor / W S Spielman ; N Parameswaran. 1st. ed. USA : Springer, 2012. pp. 61 - 74
@inbook{0abce9a271124ba1862f23fa8f766f2f,
title = "RAMPs as drug targets",
abstract = "The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.",
author = "Sexton, {Patrick M} and Poyner, {David R} and John Simms and Arthur Christopoulos and Hay, {Debbie L}",
year = "2012",
doi = "10.1007/978-1-4614-2364-5_6",
language = "English",
isbn = "9781461423638",
pages = "61 -- 74",
editor = "Spielman, {W S} and N Parameswaran",
booktitle = "RAMPs",
publisher = "Springer",
edition = "1st",

}

Sexton, PM, Poyner, DR, Simms, J, Christopoulos, A & Hay, DL 2012, RAMPs as drug targets. in WS Spielman & N Parameswaran (eds), RAMPs. 1st edn, Springer, USA, pp. 61 - 74. https://doi.org/10.1007/978-1-4614-2364-5_6

RAMPs as drug targets. / Sexton, Patrick M; Poyner, David R; Simms, John; Christopoulos, Arthur; Hay, Debbie L.

RAMPs. ed. / W S Spielman; N Parameswaran. 1st. ed. USA : Springer, 2012. p. 61 - 74.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - RAMPs as drug targets

AU - Sexton, Patrick M

AU - Poyner, David R

AU - Simms, John

AU - Christopoulos, Arthur

AU - Hay, Debbie L

PY - 2012

Y1 - 2012

N2 - The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.

AB - The receptor activity-modifying protein (RAMP) family of membrane proteins regulates G protein-coupled receptor (GPCR) function in several ways. RAMPs can alter their pharmacology and signalling as well as the trafficking of these receptors to and from the cell surface. Accordingly, RAMPs may be exploited as drug targets, offering new opportunities for regulating the function of therapeutically relevant RAMP-interacting GPCRs. For example, several small molecule antagonists of RAMP1/ calcitonin receptor-like receptor complexes, which block the actions of the neuropeptide calcitonin gene-related peptide are in development for the treatment of migraine headache.

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22434108

U2 - 10.1007/978-1-4614-2364-5_6

DO - 10.1007/978-1-4614-2364-5_6

M3 - Chapter (Book)

SN - 9781461423638

SP - 61

EP - 74

BT - RAMPs

A2 - Spielman, W S

A2 - Parameswaran, N

PB - Springer

CY - USA

ER -

Sexton PM, Poyner DR, Simms J, Christopoulos A, Hay DL. RAMPs as drug targets. In Spielman WS, Parameswaran N, editors, RAMPs. 1st ed. USA: Springer. 2012. p. 61 - 74 https://doi.org/10.1007/978-1-4614-2364-5_6